Mezun Olduğu Tıp Fakültesi ve Yılı
Lisans Tıp Fakültesi Cumhuriyet Üniversitesi, 1990-1996
Y. Lisans Tıp Fakültesi Cumhuriyet Üniversitesi, 1990-1996
Uzmanlık Eğitimi Aldığı Yer ve Yılı
Doktora/S.Yeterlik/Tıpta Uzmanlık İç Hastalıkları Kocaeli Üniversitesi, 1998-2002
Yan Dal (Tıbbi Onkoloji) Tıbbi Onkoloji Uludağ Üniversitesi, 2008-2012
Doçentlik Ünvanı Tıbbi Onkoloji, 04.04.2016
Mesleki Deneyim
Kocaeli Üniversitesi Tıp Fakültesi İç Hastalıkları Ar.Gör., 1998-2002
Kocaeli Devlet Hastanesi Uzm. Dr. (İç Hastalıkları), 2002-2008
Uludağ Üniversitesi Tıp Fakültesi Tıbbi Onkoloji BD Yan Dal Asistanı, 2008-2012
Balıkesir Devlet Hastanesi Uzm. Dr. (Tıbbi Onkoloji), 2012-2014
Ali Osman Sönmez Onkoloji Hastanesi Uzm. Dr. (Tıbbi Onkoloji), 2014-2016
Balıkesir Üniversitesi İç Hastalıkları / Medikal Onkoloji Doç. Dr. Nilüfer Avcı, 2016-2017
Medikal Park Bursa Tıbbi Onkoloji Doç. Dr. Nilüfer Avcı, 2017-2018
Medicana Bursa Tıbbi Onkoloji Doç. Dr. Nilüfer Avcı, 2018-Halen
Tıbbi İlgi Alanları
Kanser çeşitleri; Meme, Akciğer, Mide, Pankreas, Sarkomlar, Prostat, Mesane, Kolorektal
Hedefli tedaviler
Kanserli hastada ağrı ve beslenme tedavisi
Beyin tümörleri
Sertifikalar
Harvard Tıp Fakültesi, İmmüno-onkoloji alanında çevrimiçi HMX kursu başarıyla tamamladığını onayladı. Mart 27, 2026
A. Uluslararası Hakemli Dergilerde Yayımlanan Makaleler
A1. Avci N, Cecener G, Deligonul A, Erturk E, Tunca B, Egeli U, Tezcan G, Akyildiz EU, Bayram AS, Gebitekin C, Kurt E, Evrensel T. Molecular markers for patients with thymic malignancies: not feasible at present? Asian Pac J Cancer Prev. 2014;15(8):3457-60. PubMed PMID: 24870739.
A2. Ulas A, Kos T, Avci N, Cubukcu E, Olmez OF, Bulut N, Degirmenci M. Patients with HER2-positive Early Breast Cancer Receiving Adjuvant Trastuzumab: Clinicopathological Features, Efficacy, and Factors Affecting Survival. Asian Pac J Cancer Prev. 2015;16(4):1643-9. PubMed PMID: 25743846.
A3. Kanat O, Cubukcu E, Avci N, Budak F, Ercan I, Canhoroz M, Olmez F. Comparison of three different treatment modalities in the management of cancer cachexia. Tumori. 2013 Mar-Apr;99(2):229-33. doi: 10.1700/1283.14197. PubMed PMID: 23748819.
A4. Avci N, Deligonul A, Tolunay S, Cubukcu E, Fatih Olmez O, Ulas A, Hartavi M, Kurt E, Evrensel T. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer. J BUON. 2015 Jan-Mar;20(1):45-9. PubMed PMID: 25778295.
A5. Avci N, Deligonul A, Tolunay S, Cubukcu E, Olmez OF, Altmısdortoglu O, Tanrıverdi O, Kurt E, Evrensel T. Prognostic impact of tumor lymphocytic infiltrates in patients with breast cancer undergoing neoadjuvant chemotherapy. J BUON. 2015 Jul-Aug;20(4):994-1000.
A6. Cubukcu E, Olmez OF, Avci N, Canhoroz M, Kurt E, Kanat O, Evrensel T, Manavoglu O. Identification of prognostic factors in patients with metastatic gastrointestinal stromal tumors. J BUON. 2012 Jul-Sep;17(3):517-21. PubMed PMID: 23033292.
A7. Ulas A, Turkoz FP, Silay K, Tokluoglu S, Avci N, Oksuzoglu B, Alkis N. A laboratory prognostic index model for patients with advanced non-small cell lung cancer. PLoS One. 2014 Dec 4;9(12):e114471. doi: 10.1371/journal.pone.0114471. PubMed PMID: 25474743; PMCID: PMC4256446.
A8. Ulas A, Silay K, Akinci S, Dede DS, Akinci MB, Sendur MA, Cubukcu E, Coskun HS, Degirmenci M, Utkan G, Ozdemir N, Isikdogan A, Buyukcelik A, Inanc M, Bilici A, Odabasi H, Cihan S, Avci N, Yalcin B. Medication Errors in Chemotherapy Preparation and Administration: a Survey Conducted among Oncology Nurses in Turkey. Asian Pac J Cancer Prev. 2015;16(5):1699-705. PubMed PMID: 25773812.
A9. Tanriverdi O, Cokmert S, Oktay E, Pilanci KN, Menekse S, Kocar M, Sen CA, Avci N, Akman T, Ordu C, Goksel G, Meydan N. Prognostic significance of the baseline serum uric acid level in non-small cell lung cancer patients treated with first-line chemotherapy. Med Oncol. 2014 Oct;31(10):217. doi: 10.1007/s12032-014-0217-z. PubMed PMID: 25216865.
A10. Tanriverdi O, Yildirim B, Gul S, Cevik E, Akman T, Cokmert S, Pilanci KN, Avci N, Ordu C, Barutca S. Effect of lower extremity deep vein thrombosis on cancer recurrence in stage III colon cancer patients. Med Oncol. 2014 Oct;31(10):215. doi: 10.1007/s12032-014-0215-1. PubMed PMID: 25208817.
A11. Tanriverdi O et al. Clinical and pathological features of 133 colorectal cancer patients with brain metastasis: multicenter retrospective analysis. Med Oncol. 2014 Sep;31(9):152. doi: 10.1007/s12032-014-0152-z. PubMed PMID: 25108599.
A12. Yildiz I et al. Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: Turkish Oncology Group trial. Anticancer Res. 2014 Aug;34(8):4329-34. PubMed PMID: 25075067.
A13. Canhoroz M et al. Clinical significance of adiponectin expression in colon cancer patients. J Cancer Res Ther. 2014 Apr-Jun;10(2):347-53. doi: 10.4103/0973-1482.136634.
A14. Cecener G et al. BRCA1/2 germline mutations and their clinical importance in Turkish breast cancer patients. Cancer Invest. 2014 Oct;32(8):375-87. doi: 10.3109/07357907.2014.919302.
A15. Cubukcu E et al. Lack of prognostic significance of adiponectin expression in triple-negative breast cancer. Contemp Oncol (Pozn). 2014;18(1):34-8. doi: 10.5114/wo.2014.40454.
A16. Hartavi M et al. The SOCS-1 -1478CA/del polymorphism is not associated with colorectal cancer in Turkish subjects. Asian Pac J Cancer Prev. 2013;14(12):7583-6.
A17. Uyeturk U et al. Risk factors for stage IV breast cancer at presentation in Turkey. Asian Pac J Cancer Prev. 2013;14(12):7445-9.
A18. Olmez OF et al. Prognostic significance of HER-3 expression in metastatic breast cancer. Asian Pac J Cancer Prev. 2013;14(7):4115-9.
A19. Cubukcu E et al. Prognostic significance of ER, PR, HER2/neu, Ki-67, and nm23 expression in invasive breast cancer. J BUON. 2013 Apr-Jun;18(2):359-65.
A20. Olmez OF et al. c-Met expression as independent predictor of survival in glioblastoma multiforme. Clin Transl Oncol. 2014 Feb;16(2):173-7.
A21. Kurt E et al. Evaluation of carboplatin plus docetaxel regimen in elderly advanced gastric cancer patients. J BUON. 2013 Jan-Mar;18(1):147-53.
A22. Olcun Umit Unal et al. Clinicopathologic characteristics and prognostic factors of primary thoracic soft tissue sarcoma. Thoracic Cancer. 2015;6(1):85–90. doi: 10.1111/1759-7714.12150.
A23. Kocak N et al. Effects of 1alpha,25-dihydroxyvitamin D3 on doxorubicin-induced chromosomal aberrations. Acta Oncol. 2004;43(2):204-8.
A24. Akman T et al. A View from Young Oncologists on Clinical Trials in Turkey: Obstacles and Solutions. UHOD 2014;3(24):1-7.
A25. Nilüfer Avcı et al. General Characteristics of Male Breast Cancer Patients in Bursa Region. J Breast Health. 2012;8(3):126-129.
A26. Nilüfer Avcı et al. Prevalence of Herbal Product Use as Alternative Medicine Among Cancer Patients in Turkey. J Clin Anal Med. 2015;6(3):327-30.
A27. Nilüfer Avcı et al. Metaplastic Breast Cancer and EGFR Expression. J Clin Anal Med. 2015;6(5):616-9.
A28. Çubukçu S et al. Efficacy of Sunitinib in Imatinib Resistant GIST Patients. J Clin Anal Med. 2014;5(4):304-6.
A29. Ordu Ç et al. Prognostic Relevance of Sunitinib Toxicities in Metastatic Renal Cell Cancer. Contemporary Oncology. 2014.
A30. Tanriverdi O et al. Pretreatment Serum Albumin Level as Prognostic Factor in Stage IIIB NSCLC. Asian Pac J Cancer Prev. 2015;16(14):5971-6.
A31. Avci N et al. Smoking habits as independent prognostic factor in lung cancer. Clin Respir J. 2015.
A32. Nayir E et al. Tendency of cancer patients and relatives to use internet for health searches. J BUON. 2016;21(3):714-9.
A33. Deligonul A et al. HER-4 expression and prognosis in metastatic breast cancer. J BUON. 2016;21(3):564-9.
A34. Tanriverdi O et al. Mean platelet volume predicting isolated bone metastases in breast cancer. J BUON. 2016;21(4):840-850.
A35. Avcı N et al. Association and prognostic significance of -1562C/T polymorphism in MMP-9 in gastric cancer. Pathol Oncol Res. 2015;21(4):1243-7.
A36. Süner A et al. Effectiveness and safety of cabazitaxel chemotherapy in metastatic castration-resistant prostate carcinoma. Eur Rev Med Pharmacol Sci. 2016;20(7):1238-43.
A37. Artaç M et al. Bevacuzimab effectiveness in obese metastatic colorectal cancer patients. J Gastrointest Cancer. 2018.
A38. Aksoy A et al. Hormone receptor status and survival in medullary breast cancer patients. Saudi Med J. 2017;38(2):156-162.
